Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

827 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
p.G12C KRAS mutation prevalence in non-small cell lung cancer: Contribution from interregional variability and population substructures among Hispanics.
Ruiz-Patiño A, Rodríguez J, Cardona AF, Ávila J, Archila P, Carranza H, Vargas C, Otero J, Arrieta O, Zatarain-Barrón L, Sotelo C, Ordoñez C, García-Robledo JE, Rojas L, Bermúdez M, Gámez T, Mayorga D, Corrales L, Martín C, Recondo G, Mas L, Samtani S, Ricaurte L, Malapelle U, Russo A, Barrón F, Santoyo N, Rolfo C, Rosell R; ONCOLGroup; CLICaP. Ruiz-Patiño A, et al. Among authors: rosell r. Transl Oncol. 2022 Jan;15(1):101276. doi: 10.1016/j.tranon.2021.101276. Epub 2021 Nov 22. Transl Oncol. 2022. PMID: 34823093 Free PMC article.
Ifosfamide in non-small-cell lung cancer.
Rosell R, Martin C, Balaña C. Rosell R, et al. Ann Oncol. 1999;10 Suppl 5:S25-8. doi: 10.1093/annonc/10.suppl_5.s26. Ann Oncol. 1999. PMID: 10582135 Free article. Review.
BRCA1: a new genomic marker for non-small-cell lung cancer.
Reguart N, Cardona AF, Carrasco E, Gomez P, Taron M, Rosell R. Reguart N, et al. Among authors: rosell r. Clin Lung Cancer. 2008 Nov;9(6):331-9. doi: 10.3816/CLC.2008.n.048. Clin Lung Cancer. 2008. PMID: 19073515 Review.
Genotyping non-small cell lung cancer (NSCLC) in Latin America.
Arrieta O, Cardona AF, Federico Bramuglia G, Gallo A, Campos-Parra AD, Serrano S, Castro M, Avilés A, Amorin E, Kirchuk R, Cuello M, Borbolla J, Riemersma O, Becerra H, Rosell R; CLICaP. Arrieta O, et al. Among authors: rosell r. J Thorac Oncol. 2011 Nov;6(11):1955-9. doi: 10.1097/JTO.0b013e31822f655f. J Thorac Oncol. 2011. PMID: 22005474 Free article.
Phase I/II trial of vorinostat (SAHA) and erlotinib for non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations after erlotinib progression.
Reguart N, Rosell R, Cardenal F, Cardona AF, Isla D, Palmero R, Moran T, Rolfo C, Pallarès MC, Insa A, Carcereny E, Majem M, De Castro J, Queralt C, Molina MA, Taron M. Reguart N, et al. Among authors: rosell r. Lung Cancer. 2014 May;84(2):161-7. doi: 10.1016/j.lungcan.2014.02.011. Epub 2014 Mar 2. Lung Cancer. 2014. PMID: 24636848 Clinical Trial.
827 results